THRX

Theseus Pharmaceuticals, Inc. Common Stock
THRX

Delisted

THRX was delisted on the 13th of February, 2024.

Back to rankings

46 hedge funds and large institutions have $441M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$214M
2
+$69.1M
3
+$40.7M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$16.2M
5
BC
Boxer Capital
California
+$11.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$281K
27
$222K
28
$217K
29
$190K
30
$190K
31
$144K
32
$123K
33
$100K
34
$89K
35
$86K
36
$80K
37
$78K
38
$65K
39
$45K
40
$40K
41
$34K
42
$29K
43
$27K
44
$21K
45
$13K
46
$11K
1
2